ATAGI says Novavax vaccine for primary shots, not boosters

The first protein-based COVID-19 vaccine approved in Australia is expected to roll out from late February

ATAGI has recommended the Novavax vaccine be used for a primary course of COVID-19 inoculation — including as part of a mixed schedule — but not as a booster.

The spike protein-based adjuvanted vaccine, branded Nuvaxovid, was provisionally approved by the TGA last week.